Galapagos Biopharma Denmark ApS — Credit Rating and Financial Key Figures

CVR number: 42447242
Sundkrogsgade 21, 2100 København Ø

Income statement (kDKK)

2021
2022
2023
Fiscal period length121212
Net sales
Gross profit5 080.5113 808.7711 777.53
Employee benefit expenses-4 557.53-11 917.00-10 001.87
EBIT522.991 891.771 775.66
Other financial income24.7295.62
Other financial expenses-12.41-62.36-88.49
Pre-tax profit510.581 854.131 782.79
Income taxes- 112.33- 408.19- 393.21
Net earnings398.251 445.941 389.58

Assets (kDKK)

2021
2022
2023
Intangible assets total
Tangible assets total
Investments total103.50139.00139.00
Long term receivables total
Inventories total
Current trade debtors5 616.38
Current amounts owed by group member comp.5 616.3816 291.876 099.76
Prepayments and accrued income166.73248.25254.14
Current other receivables-5 519.01369.48791.38
Short term receivables total5 880.4716 909.607 145.27
Cash and bank deposits3 604.14
Cash and cash equivalents3 604.14
Balance sheet total (assets)9 588.1117 048.607 284.27

Equity and liabilities (kDKK)

2021
2022
2023
Share capital40.0040.0040.00
Retained earnings398.251 844.19
Profit of the financial year398.251 445.941 389.58
Shareholders equity total438.251 884.193 273.77
Non-current liabilities total
Current trade creditors204.941 352.321 023.23
Current owed to participating5 978.2311 309.99
Short-term deferred tax liabilities112.33408.10365.11
Other non-interest bearing current liabilities2 854.362 094.002 622.15
Current liabilities total9 149.8515 164.414 010.50
Balance sheet total (liabilities)9 588.1117 048.607 284.27
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.